Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination therapy in patients (pts) with advanced melanoma (MEL) - Sznol, Mario; Hassel, Jessica C. (Annals of oncology, 2016)
Gesehen am 14.11.2017